Anant Raj an outperformer: Prabhudas Lilladher

Published on Tue, Jun 03, 2008 at 14:21 |  Source : Moneycontrol.com

Updated at Tue, Jun 03, 2008 at 14:27  

5814 Investors following Anant Raj Ind. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

Prabhudas Lilladher has maintained its outperformer rating on Anant Raj Industries with a target price of Rs 282 in its June 2, 2008 research report. "Anant Raj Industries' (ARIL) results were broadly in line with our estimates. However, the reported topline of Rs 6.03 billion was net of cost of investments. The company's topline grew 190%, with strong EBIDTA margin of 93.1%. Its PAT stood at Rs 4.37 billion, YoY growth of 248%."

"We expect strong topline growth of 102% and 112% to Rs 122.2 billion and Rs 258.9 billion in FY09 and FY10 respectively. For the corresponding period, EBIDTA margins are likely to be 69.4% and 65% respectively. The company is expected to report strong PAT growth of 44% and 101% in FY09 and FY10 respectively. Our working of the company's NAV stands at Rs 332. Our target price of Rs 282 is based on 15% discount to NAV. We maintain Outperformer rating on the stock," says Lilladher's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

For further details click on attachment......

  

More on Moneycontrol

Trending News

Business News

Tech2's Nokia Lumia Contest is Live
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com